Will 2020 be year of pharma sector, Infosys panel gives clean chit on whistle-blower complaint; all this and more on Moneycontrol Pro

  • It has been hit on fronts such as stricter US FDA compliance rules, tighter rules and falling prices in the US generic market

  • The Infosys committee determined that there was no evidence of any financial impropriety or executive misconduct

  • Moneycontrol Pro offers curated markets data, independent equity analysis, insights into investment styles and exclusive trading recommendations

Finally, some great news! India’s fastest-growing financial subscriptions service, Moneycontrol Pro, is available both on the website and mobile apps.

Moneycontrol Pro offers curated markets data, independent equity analysis, insights into investment styles and exclusive trading recommendations. In sum, all the information you need for wealth creation.

Will 2020 be the year of the pharma sector?

Over the last few years very few companies, let alone sectors, have participated in the market rally. One sector that has been all but forgotten by the market is the pharmaceuticals industry. It has been hit on fronts such as stricter US FDA compliance rules, tighter rules and falling prices in the US generic market. What should investors do? Read more.

 Will 2020 be year of pharma sector, Infosys panel gives clean chit on whistle-blower complaint; all this and more on Moneycontrol Pro

Representational image

How mild steel slabs rescued the Index of Industrial Production

Growth in the Index of Industrial Production (IIP) came in at 1.8 percent year-on-year for November 2019, according to data from the Central Statistics Office. But data shows that all 1.8 percentage points of that growth was contributed by MS slabs aka mild steel slabs. In other words, growth in the rest of industry was zero. Read more.

Tax-planning 2020: Are you saving taxes today for a messy financial future?

It’s that time of the year when we start thinking about investing in tax savings instruments. That’s all good but we tend to forget financial planning and our larger financial goals when we do our tax-planning. Most tax-saving instruments are not liquid; that’s a trade-off for tax benefits that you get on them. Read more.

Infosys Q3: Clean chit on whistle-blower complaint and healthy financials

The key takeaway from Infosys’s Q3 FY20 results does not pertain to the numbers but to the report of the audit committee that examined an anonymous whistle blower’s complaints. The committee determined that there was no evidence of any financial impropriety or executive misconduct. The numbers were good too with a small improvement in margin and upward revision of revenue guidance. What should investors do? Read more.

A high quality consumption stock which is likely to outperform

This firm is the second largest player in the kitchen appliances market and has a proven track record of growth. New product launches are propelling sales growth while increasing cooking gas penetration is expanding its market in rural areas. Its valuations appear reasonable for accumulation. Read more.

Chart of the Day: The takeaway from falling real rural wages

Picks from our technical analysts (Please click on security name to access recos)

Piramal Enterprises
Creditaccess Grameen
Lumax Industries
Indusind Bank

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

Updated Date: Jan 13, 2020 13:13:55 IST